cytomegalovirus infection in ICU patients

Not Applicable

• Conditions: Health Condition 1: B258- Other cytomegaloviral diseases

• Registration Number: CTRI/2022/03/040943
• Lead Sponsor: SERB DST

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 4 April 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

All consecutive mechanically ventilated (at least >72h) adult septic patients (non-immuno compromised) with CMV seropositive status will be considered for inclusion in the study.

Exclusion Criteria

1.Consent not given.

2.Expected survival <72 hours.

3.Use of antiviral agent cidofovir, foscarnet, ganciclovir, valganciclovir, scyclovir within the last 7 days.

4.Known or suspected underlying immune deficiency [history of solid organ or stem cell transplantation, infection with the human immunodeficiency virus, hematological malignancy, use of immunosuppressive medication (more than 0.1 mg prednisone per kilo for more than 3 months, more than 75 mg prednisone per day for more than 1 week, or equivalent), chemotherapy/radiotherapy in the year before ICU admission, and any known humoral or cellular immune deficiency].

5.Pregnancy.

6.Patients with surgical complications or trauma.

Study & Design

• Study Type: Observational
• Study Design: Not specified